Unlike growth hormone peptides (which work through the pituitary) or GLP-1 peptides (which work through gut and brain receptors), BPC-157 works primarily through a different mechanism: it upregulates growth hormone receptors in tendon cells, stimulates angiogenesis (the formation of new blood vessels), and modulates nitric oxide signaling all of which contribute to accelerated tissue repair and reduced inflammation
Jaka Vukojevi, Marija Milavi, Darko Perovi, Spomenko Ili, Andrea Zemba ili, Nataa uran, Sanja trbe, Zoran Zorii, Igor Filipi, Petrana Brei, Sven Seiverth, & Predrag Sikiri
The combined protocol shockwave plus PRP plus BPC-157 stacks three mechanisms that work differently and reinforce each other
Products remain research-use only
It is based on a novel oral formulation of BPC-157 and TB-500 designed for tissue repair and recovery, available through preferred research peptides vendor